The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmid steady demand for consumer staples, Colgate-Palmolive has received a consensus 'Moderate Buy' recommendation from 19 brokerage firms. Analysts have set the average 12-month price target for the stock at $96.59. This optimism is driven by strong financial performance, as the company reported Q1 earnings per share of $0.97, exceeding estimates alongside a notable 8.4% year-over-year revenue increase.
Colgate-Palmolive's current performance stands out among consumer sector peers, supported by a steady dividend yield of approximately 2.3%, enhancing its appeal to income-focused investors. Compared to competitors, the Q1 results demonstrated margin resilience despite global inflationary pressures. Per market data, the company's focus on innovation in oral care and personal hygiene has helped maintain its market share against giants like Procter & Gamble.
CL stock closed at $91.47 (close July 15, 2026), with daily trading ranging between $89.59 and $92.01. Looking ahead, traders are awaiting the U.S. Monetary Policy Report on July 10, 2026, which may influence market sentiment toward defensive stocks. Additionally, speeches from Fed officials Bowman and Waller on July 13 will be closely monitored for any shifts in borrowing costs that could impact retail sector valuations.